XTL Biopharmaceuticals Ltd. (XTLB) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 | Q1'21 | Q4'20 | Q3'20 | Q2'20 | Q1'20 |
|---|
| Total Current Assets | 1.34M | 1.99M | 2.02M | 2.55M | 2.05M | 2.28M | 2.5M | 2.94M | 3.81M | 4.52M | 5.38M | 6.24M | 6.24M | 6.47M | 6.57M | 6.93M | 6.12M | 5.83M | 6.41M | 6.89M |
| Cash & Short-Term Investments | 1.14M | 1.72M | 1.59M | 2.34M | 2.01M | 2.21M | 2.38M | 2.88M | 3.72M | 4.39M | 5.16M | 2.79M | 6.13M | 3.01M | 6.3M | 3.39M | 6.04M | 3.75M | 4.03M | 4.26M |
| Cash Only | 371K | 820K | 594K | 1.07M | 1.4M | 1.46M | 1.59M | 1.9M | 2.09M | 2.23M | 2.35M | 2.79M | 2.97M | 3.01M | 2.92M | 3.39M | 3.63M | 3.75M | 4.03M | 4.26M |
| Short-Term Investments | 772K | 900K | 992K | 1.27M | 605K | 749K | 794K | 972K | 1.63M | 2.16M | 2.81M | 0 | 3.16M | 0 | 3.38M | 0 | 2.41M | 0 | 0 | 0 |
| Accounts Receivable | 99K | 140K | 304K | 150K | 29K | 0 | 0 | 0 | 71K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | 38.04 | 126.07 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 47K | 0 | 0 | 0 | 11K | 0 | 0 | 0 | -57K | 0 | 0 | 3.45M | 16K | 3.46M | 0 | 3.54M | 13K | 2.08M | 2.38M | 2.63M |
| Total Non-Current Assets | 7.21M | 7.29M | 380K | 380K | 380K | 380K | 380K | 380K | 380K | 380K | 381K | 381K | 381K | 382K | 382K | 382K | 382K | 382K | 381K | 382K |
| Property, Plant & Equipment | 187K | 217K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1K | 0 | 1K | 0 | 2K | 0 | 2K | 0 | 0 | 0 |
| Fixed Asset Turnover | 1.43x | 0.75x | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 3.19M | 0 | 0 | 0 | 0 | 379.62K | 379.62K | 379.62K | 0 | 379.62K | 379.62K | 0 | 0 | 0 | 379.62K | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 3.82M | 7.08M | 380K | 380K | 380K | 380 | 380 | 380 | 380K | 380 | 380 | 0 | 380K | 0 | 380 | 0 | 380K | 0 | 0 | 0 |
| Long-Term Investments | 14K | 0 | 0 | 0 | -604.39K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 604.39K | 0 | 0 | 0 | 0 | 0 | 0 | 381K | 0 | 382K | 0 | 382K | 0 | 382K | 381K | 382K |
| Total Assets | 8.55M | 9.28M | 2.4M | 2.93M | 2.43M | 2.66M | 2.88M | 3.32M | 4.19M | 4.9M | 5.76M | 6.62M | 6.62M | 6.86M | 6.95M | 7.31M | 6.5M | 6.21M | 6.79M | 7.27M |
| Asset Turnover | 0.03x | 0.03x | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 252.43% | 248.48% | -16.77% | -11.86% | -42.04% | -45.62% | -49.96% | -49.83% | -36.75% | -28.56% | -17.2% | -9.44% | 1.77% | 10.39% | 2.42% | 0.58% | -9.83% | -25.08% | -28.9% | -41.54% |
| Total Current Liabilities | 2.21M | 2.47M | 165K | 223K | 206K | 162K | 163K | 241K | 187K | 153K | 172K | 260K | 231K | 185K | 258K | 251K | 254K | 182K | 194K | 244K |
| Accounts Payable | 196K | 554K | 165K | 223K | 1K | 162K | 163K | 241K | 2K | 153K | 172K | 0 | 2K | 185K | 258K | 0 | 2K | 0 | 0 | 0 |
| Days Payables Outstanding | 103.92 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 138K | 168K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 18K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 1.33M | 1.75M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Ratio | 0.61x | 0.81x | 12.23x | 11.43x | 9.93x | 14.09x | 15.34x | 12.21x | 20.35x | 29.52x | 31.26x | 24.00x | 27.00x | 34.99x | 25.47x | 27.61x | 24.10x | 32.02x | 33.03x | 28.23x |
| Quick Ratio | 0.61x | 0.81x | 12.23x | 11.43x | 9.93x | 14.09x | 15.34x | 12.21x | 20.35x | 29.52x | 31.26x | 24.00x | 27.00x | 34.99x | 25.47x | 27.61x | 24.10x | 32.02x | 33.03x | 28.23x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 908K | 1.1M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 22K | 517K | 1.05M | 3.59M | 3.41M | 2.69M | 2.64M | 0 | 0 | 0 |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 219K | 331K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 689K | 765K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 22K | 517K | 1.05M | 3.59M | 3.41M | 2.69M | 2.64M | 0 | 0 | 0 |
| Total Liabilities | 3.12M | 3.56M | 165K | 223K | 206K | 162K | 163K | 241K | 187K | 153K | 194K | 777K | 1.28M | 3.78M | 3.67M | 2.94M | 254K | 182K | 194K | 244K |
| Total Debt | 138K | 168K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Debt | -233K | -652K | -594K | -1.07M | -1.4M | -1.46M | -1.59M | -1.9M | -2.09M | -2.23M | -2.35M | -2.79M | -2.97M | -3.01M | -2.92M | -3.39M | -3.63M | -3.75M | -4.03M | -4.26M |
| Debt / Equity | 0.03x | 0.03x | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | -2.20x | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -13.31x | -4.95x | -53.15x | 30.31x | - | -6.68x | -10.38x | -35.76x | - | - | -24.91x | 57.22x | -71.50x | 66.50x | -81.71x | -33.14x | - | - | -102.56x | - |
| Total Equity | 5.43M | 5.72M | 2.23M | 2.71M | 2.22M | 2.5M | 2.72M | 3.08M | 4M | 4.74M | 5.56M | 5.84M | 5.33M | 3.08M | 3.28M | 4.37M | 6.25M | 6.03M | 6.59M | 7.03M |
| Equity Growth % | 144.82% | 128.59% | -17.84% | -12.2% | -44.49% | -47.28% | -51.14% | -47.28% | -25.01% | 54.08% | 69.5% | 33.82% | -14.66% | -48.92% | -50.23% | -37.84% | -10.47% | -25.48% | -29.43% | -42.41% |
| Book Value per Share | 49.40 | 67.14 | 26.23 | 31.77 | 26.07 | 29.37 | 31.92 | 36.19 | 46.97 | 55.72 | 65.34 | 68.64 | 59.18 | 36.64 | 39.80 | 53.01 | 77.78 | 75.03 | 82.08 | 87.44 |
| Total Shareholders' Equity | 5.43M | 5.72M | 2.23M | 2.71M | 2.22M | 2.5M | 2.72M | 3.08M | 4M | 4.74M | 5.56M | 5.84M | 5.33M | 3.08M | 3.28M | 4.37M | 6.25M | 6.03M | 6.59M | 7.03M |
| Common Stock | 23.14M | 23.14M | 14.12M | 14.12M | 14.12M | 14.12M | 14.12M | 14.12M | 14.12M | 14.12M | 14.12M | 5.84M | 14.12M | 3.08M | 13.6M | 4.37M | 13.18M | 6.03M | 6.59M | 7.03M |
| Retained Earnings | -159.01M | -158.77M | -158.23M | -157.76M | -158.25M | -157.97M | -157.75M | -157.38M | -156.47M | -155.72M | -154.9M | 0 | -155.13M | 0 | -156.45M | 0 | -154.66M | 0 | 0 | 0 |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 20K | 20K | 20K | 20K | 20K | 20K | 20K | 20K | 20K | 20K | 20K | 0 | 20K | 0 | 20K | 0 | 20K | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |